Similar companies
Income Statement (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Revenue | 23.7B | 8.5% |
| Gross Profit | 16.1B | 10.9% |
| Cost of Revenue | 7.63B | 3.7% |
| Operating expense | 9.41B | 14.2% |
| Net Income | 5.54B | 49.7% |
| EBITDA | 6.49B | 58.4% |
Balance Sheet (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Total Assets | 193B | 0.1% |
| Total Liabilities | 115B | 0.6% |
| Total Equity | 78.5B | 0.5% |
| Shares Outstanding | 2.42B | 0.2% |
Cash Flow (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Cash from operations | 3.88B | 7.1% |
| Cash from investing | -18.3B | 6049.5% |
| Cash from financing | -5.67B | 154.4% |
EPS
Financial Highlights for Johnson & Johnson in Q2 '25
Johnson & Johnson reported a revenue of 23.7B, which is a 8.5% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 16.1B, marking a 10.9% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 7.63B, a 3.7% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 9.41B, showing a 14.2% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 5.54B, showing a -49.7% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 6.49B, showing a -58.4% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Johnson & Johnson faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.
